Shield Therapeutics (1JS) Cash flow

2 Followers

Shield Therapeutics Cash Flow

DE:1JS's free cash flow for Q2 2026 was £712.11K. For the 2026 fiscal year, DE:1JS's free cash flow was decreased by £-32.18K and operating cash flow was £739.89K. See a summary of the company’s cash flow.

Cash Flow	Mar 26	Dec 24	Dec 23	Dec 22	Jun 22
Operating Cash Flow	$ -8.81M	$ -8.77M	$ -46.93M	£ -18.25M	£ -16.74M
Investing Cash Flow	$ -306.29K	$ -2.37M	$ -3.07M	£ -1.70M	£ -2.05M
Financing Cash Flow	$ 13.75M	$ 5.26M	$ 62.77M	£ 7.71M	£ 27.58M
End Cash Position	$ 11.63M	$ 7.02M	$ 17.63M	£ 2.82M	£ 12.12M
Free Cash Flow	$ -8.83M	$ -8.80M	$ -50.65M	£ -20.14M	£ -18.80M